Track insider trades on the go.
Get the app!
iOS
Android
Insider Trades
Latest Trades
Companies
Insiders
Insights
Get the App
Open menu
Back to Trades
Inhibikase Therapeutics, Inc.
IKT
CIK: 0001750149
Total Volume
$16.8M
Purchases
$3.0M
Sales
$0
Unique Insiders
6
Recent Insider Trades (7)
Inhibikase Therapeutics, Inc.
(IKT)
Iwicki Mark T
Insider
Filed Jan 7, 2026
Other
$0
View Details
SEC Filing
Inhibikase Therapeutics, Inc.
(IKT)
Cabell Christopher
Insider
Filed Jan 7, 2026
Other
$0
View Details
SEC Filing
Inhibikase Therapeutics, Inc.
(IKT)
McIntyre David
Insider
Filed Jan 7, 2026
Other
$0
View Details
SEC Filing
Inhibikase Therapeutics, Inc.
(IKT)
Sands Capital Life Sciences Pulse Fund II, L.P.
10% Owner
Filed Nov 24, 2025
Buy
$3.0M
1 buy
View Details
SEC Filing
Inhibikase Therapeutics, Inc.
(IKT)
Aurentz Vincent
Insider
Filed Aug 28, 2025
Other
$0
View Details
SEC Filing
Inhibikase Therapeutics, Inc.
(IKT)
Cabell Christopher
Insider
Filed Aug 28, 2025
Other
$0
View Details
SEC Filing
Inhibikase Therapeutics, Inc.
(IKT)
Munshi Amit
Insider
Filed Aug 28, 2025
Grant
$0
1 grant
View Details
SEC Filing